INTRODUCTION
Hepatic angiosarcoma is a very rare mesenchymal malignancy accounting for ＜2% of all primary liver tumors. 1 Its epidemiological data are limited and, in most cases, etiology is not clearly defined. 2 Some studies have suggested that hepatic angiosarcomas were associated with chronic exposure to thorotrast, vinyl chloride, arsenic, radium, and anabolic steroids, and were possibly related to alcoholic cirrhosis and chronic idiopathic hemochromatosis. 3, 4 Early diagnosis of hepatic angiosarcoma is difficult owing to its non-specific symptoms, including abdominal pain,
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The Korean Journal of Gastroenterology weakness, and weight loss. 3 In addition, the radiological features of hepatic angiosarcoma are not easily differentiated from those of hemangioma or other liver malignancies.
Characterized by a rapid progression, high recurrence rate, and resistance to traditional chemotherapy and radiotherapy, the patient survival rate for hepatic angiosarcoma is very low. [5] [6] [7] Since only a small portion of tumors are resectable at the initial diagnosis, curative liver resection is limited.
In previous studies few patients exhibited long-term survival after hepatectomy. [8] [9] [10] [11] [12] Therefore, we retrospectively reviewed the clinical features, radiologic findings, and treatment outcomes of eight patients with histologically confirmed primary hepatic angiosarcoma, in order to attain a better understanding of the disease by providing additional clinical data. 
SUBJECTS AND METHODS

Patients
Diagnosis
Radiological diagnoses were based on a review of the ra- Immunohistochemical staining for CD31, CD34, and factor VIII-related antigen was performed to determine tumor origin; samples were confirmed as vascular tumors originating from endothelial cells when at least one of these factors was present.
Statistical analyses
Statistical analyses were performed using SPSS software for Windows (version 12.0; SPSS Inc., Chicago, IL, USA).
Frequency variables were represented as frequencies with percentages. Overall survival rates were estimated using the Kaplan-Meier method. The following treatment variables (aggressive versus conservative) were compared using a log-rank test. A p-value of ＜0.05 was considered statistically significant.
Ethics statement
This study was approved by the instituitional review board of Keimyung University Dongsan Hospital (IRB No. 12-219).
Informed consent was waived by the board.
RESULTS
Characteristics of patients with primary hepatic angiosarcoma
Patient characteristics are shown in 
Radiologic findings of primary hepatic angiosarcoma
Five patients had multiple hepatic lesions with bilobular distribution. Among the four classifying growth patterns, [13] [14] [15] five patients had a mixed dominant mass with nodules, two had multiple nodules, and one had a large solitary mass (Table 1) . Non-enhanced CT showed hypoattenuated lesions with or without hyperattenuated foci in six patients. Contrastenhanced CT showed hypoattenuated lesions with centrally enhanced foci in six patients (Fig. 1) . One patient showed an isoattenuated lesion with centrally enhanced foci and one patient showed a hypoattenuated lesion with peripheral ring enhancement ( Fig. 2) . Compared with the aorta, focally enhanced areas showed less attenuation and were irregularly shaped with central or peripheral ring enhancement. A delayed progressive enhancement pattern was observed in all enhanced lesions, except in one patient whose lesion was hypoattenuated with a peripheral ring enhancement. A typical enhancement pattern was found in five patients (Table 1) . The initial CT-based diagnoses were hepatocellular carcinoma (n=2), hemangioma (n=2), and hepatic metastatic carcinoma (n=2), and primary hepatic angiosarcoma (n=2).
Immunohistochemical diagnostic features of primary hepatic angiosarcoma
A definitive diagnosis was based on a percutaneous needle biopsy in seven patients and surgical resection in one. The gross morphology of cut section showed reticular and cystic structure with formation of many large blood vessels. The vessels were irregular and mixed with grayish white solid structure. Tumor cells grew along the existing sinusoids, cen- tral veins, and portal vein branches, leading to vessel obstruction and dilatation and the formation of purpura, as well as solid hemorrhage and necrosis (Fig. 3A) .
Microscopic morphology showed diffuse growth of pleomorphic and hyperchromatic tumor cells with anastomosing vascular channels, lined by atypical endothelial cells (Fig. 3B ).
Liver tissues of all patients stained positive for at least one of CD31, CD34, or factor VIII-related antigens. Two patients were positive for CD31, CD34, and factor VIII-related antigen, three were positive for CD31 and factor VIII-related antigen;
one was positive for CD31 and CD34; one was positive for CD34 and factor VIII-related-antigen; and one was positive only for CD31 (Table 1 and Fig. 3C ).
Treatment and prognosis of patients with primary hepatic angiosarcoma
A number of patients presented with advanced stage at the initial diagnosis. Extrahepatic metastases were detected in three patients (37.5%), with sites including the spleen and lung, pericardium and lung, and bone in one patient each.
Treatment regimens are shown in Table 1 of the eight patients in the current study. 1, 19, 20 Determining the morphological changes that occur as a multiple nodular liver lesion progresses toward a diffuse infiltrative micro-nodular liver lesion could be useful in aiding the diagnosis of hepatic angiosarcoma. 21 In addition, heterogeneous signal intensities and central septal-like progressive enhancement on MRI scans might be suggestive of hepatic angiosarcoma. 22 Considering the probability of differential diagnoses based on radiological examination alone, a histological examination is recommended as the best approach to confirm primary hepatic angiosarcoma. However, the vascular nature of hepatic angiosarcoma implies a tendency toward hemorrhage, which can make percutaneous biopsy dangerous. 23 In this study, none of the patients who underwent a percutaneous needle biopsy showed any signs of hemorrhage or inflammation. Furthermore, based on the histological analyses here, the radiological data was only accurate in two of the Kaposi's sarcoma, fibrosarcoma, and leiomyosarcomas require pathological examination for differentiation. 26 Immunohistochemical staining can be used to confirm the histological findings. All patients in the current study had confirmed vascular tumors originating from endothelial cells, in that each stained positive for CD31, CD34, or factor VIII-related antigens.
In the current study metastases from hepatic angiosarcoma were noted in the spleen, lung, pericardium, and bone. 27 This is likely because diagnosis of angiosarcoma is often delayed because of its non-specific symptoms. In most cases, patients present with advanced stage disease because of the rapid progression and growth of the tumor, further suggesting the need for more information on the course of angiosarcoma to prevent an erroneous differential diagnosis.
For treatment, if a lesion is local, surgical resection is recommended. 28 Zhou et al. 11 reported an increase in overall survival of ＞10 months after complete surgical resection. In the current study, one patient with localized hepatic angiosarcoma without metastasis underwent successful surgical resection, but died due to cancer recurrence after 74 days, which was much less than the median overall survival time.
Such poor prognosis, despite successful surgical resection, Hepatic angiosarcoma has a high recurrence rate and a low postoperative survival rate, as demonstrated in the current study, where the median and mean survival times were ＜8 months. The longest survival time noted to date is ~28 months. [27] [28] [29] Park et al. 18 reported that patients with a tumor response after TACE survived for ＞ 8 months. Locker et al. 3 reported that 2 out of 4 patients who had chemotherapy died within 3 months of diagnosis; the other 2 survived for ＞6 months, but prognosis was very poor and the median survival time without aggressive treatment was ＜6 months, 1,3 with only 3% of the patients having survived longer than 3 years. 3 Overall, prognosis for angiosarcoma is dismal, further supporting the need for standardized diagnostic protocols.
In conclusion, to improve the prognosis for patients with hepatic angiosarcoma, extensive analysis including a histological examination is crucial for early diagnosis to enable appropriate treatment, such as surgical resection, prior to rapid tumor expansion or development of metastases. In addition, development of more effective systemic, local, or molecular-targeted therapies is urgently required in order to improve clinical outcome.
